Cosmetic Labeling Manual - Cosmetic Labeling Guide
Cosmetic Labeling Manual - Cosmetic Labeling Guide
Cosmetic Labeling Manual - Cosmetic Labeling Guide
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
Home > Cosmetics > Cosmetic Labeling & Label Claims > Cosmetic Labeling Manual
Cosmetics
Cosmetic Labeling Guide
From the Cosmetic Labeling Manual 1 October 1991
Contents
Laws Regulating Cosmetic Labeling Legal Definitions of Terms Principal Display Panel Placement of Information on Labels Prominence and Conspicuousness Language Type Size Identity Labeling Name and Place of Business Net Quantity of Contents Declaration Warning Statement Ingredient Labeling Prominence Ingredient Identification Order of Declaration Fragrances and Flavors Trade Secret Ingredients Petitioning for Trade Secrecy Drug Ingredients Color Additives Added for Color Matching Incidental Ingredients Dissimilar Product Assortments Similar Product Assortments Branded Shade Lines Direct Mail Cosmetics Off-Package Ingredient Labeling The cosmetics marketed in the United States, whether they are manufactured here or are imported from abroad, must comply with the labeling requirements of the Federal Food, Drug, and Cosmetic (FD&C) Act, the Fair Packaging and Labeling (FP&L) Act, and the regulations published by the Food and Drug Administration under the Authority of these two laws. The FD&C Act was enacted by Congress to protect consumers from unsafe or deceptively labeled or packaged products by prohibiting the movement in interstate commerce of adulterated or misbranded food, drug devices and cosmetics.
1 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
To ensure that packages and their labels provide consumers with accurate information about the quantity of contents and facilitate value comparisons.
15 U.S.C. 1451-1460 The FD&C Act prohibits the marketing of cosmetics that are adulterated or misbranded as well as their adulteration or misbranding while in interstate commerce.
What is a cosmetic?
A cosmetic is a product, except soap, intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering the appearance.
Sec. 201(i) FD&C Act According to Senate Report No. 493 and court decisions, the term "intended" in the legal definition of the term "cosmetic" or in other definitions means, with respect to the use of a product, its directed or prescribed use as determined from the statements made on a product's label or labeling. The courts, in deciding whether a product is a "cosmestic", a "drug", or both a "drug" and a "cosmetic", have relied principally on
2 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
the consumer's perception of the meaning of a label statement and less so on the interpretation of the meaning of a label statement by the labeler or a regulatory agency.
"Intended use" within the meaning of the FD&C Act is determined from its label or labeling.
Senate Report No. 493 73d Cong. 2d Sess. (1934) U.S. Courts of Appeals Decisions A cosmetic is legally also a drug if it is intended to exert a physical as well as a physiological effect because the FD&C Act defines in section 201(g) the term "drug" to mean, among other things, "articles intended for use in the ... cure, mitigation, treatment, or prevention of disease ... and ... articles ... intended to affect the structure or any function of the body ..." Section 509 of the FD&C Act provides that the categories of "drug" and "cosmetic" are not mutually exclusive.
A container or wrapping, other than a shipping container or wrapping, in which a consumer commodity is delivered or displayed to retail purchasers.
Sec. 10(b), FP&L Act 21 CFR 1.20 The term "label" is defined in the FD&C Act and the FP&L Act. The definitions differ in that under the FD&C Act definition a label is "a display of written, printed or graphic matter upon the immediate container," and under the FP&L Act definition "written, printed or graphic matter affixed to any consumer commodity or affixed to or appearing upon a package containing any consumer commodity." One may say that the term "label" applies in the first instance to the information appearing directly on the immediate container and in the second instance to information attached to the immediate container and directly on or attached to the outer container if so packaged. The FD&C Act, however, requires in sec 201(k) that any information required to appear on the label of the immediate container shall also appear on the outside container of the retail package or is legible through the outside container.
Package
Label
3 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
The FD&C Act defines in sec. 201(m) "labeling" to mean "all labels and other written, printed or graphic matter on or accompanying such article." This includes labels, inserts, risers, display packs, leaflets, promotional literature or any other written or printed information distributed with a product.
All labels and other written, printed or graphic material on or accompanying a product in interstate commerce or held for sale
Sec. 201(m), FD&C Act 21 CFR 1.3(a) A label may consist of more than one panel. It may consist of a front panel, side panels and a back panel. Back and side panels are generally called information panels. The FP&L Act also defines for consumer commodities, or packages containing a consumer commodity, the term "principal display panel," otherwise known for short as PDP. The "principal display panel" is that part of a panel that is most likely to be shown or examined under customary conditions of display for retail sale. Usually, it is the front panel of the label of the outer package.
Labeling
The part of a label that the consumer sees or examines when displayed for retail sale
Sec. 10(t), FP&L Act 21 CFR 701.10 As mentioned before, the PDP is that part of the label that is most likely to be shown or examined under customary conditions for retail sale. Regulations [21 CFR 701.10] published by the FDA require that the PDP be large enough to accommodate all required label information with clarity and conspicuousness. If a package bears more than one PDP, the information required to be placed on the PDP must be duplicated on all PDPs. For the purpose of assuring uniform type size for declaring a product's net quantity of contents, the size of the surface area bearing the PDP, and not the size of the PDP itself, is the determining factor. The area of the PDP is for a: Rectangular package: One entire side. Cylindrical package: 40% of height x circumference. Any other shape of container: 40% of total container surface, excluding top, bottom, neck, shoulder, flanges. The PDP of a "boudoir-type" or decorative cosmetic container, e.g., cartridge, pill box, compact or special variety, and those containing 1/4 oz or less may be a tear-away tag or tape affixed to the container [21 CFR 701.13(e)(1)]. It may also be the display panel of a card to which the immediate container is affixed [21 CFR 701.13(e)(2)].
4 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
740.10 warning
The following information must appear on the label of the inner (immediate) container holding the cosmetic product. The inner container is packaged and displayed in a non-transparent box, folding carton etc. If the outer container is removed and the product displayed for sale without it, the label of the immediate container becomes a label of an outer container.
Language
English language statements Foreign language statements
21 CFR 701.2(b) Ingredient Declaration: Generally, in letters not less than 1/16" in height [21 CFR 701.3(b)]. If surface area available to bear label (excludes surfaces with decorative relief, sculptured surfaces) is less than 12 square inches, letter height may be not less
5 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
than 1/32" [21 CFR 701.3(p)]. Net Contents Declaration on PDP: Minimum letter height determined by the area of the PDP. In the case of "boudoir-type" containers, including decorative cosmetic containers of the cartridge, pill box, compact or pencil type, and cosmetics of 1/4 oz. or less capacity, the type size is determined by the total dimensions of the container. If the container is mounted on a display card, the display panel determines the letter height [21 CFR 701.13(e) and (i)]. Warning Statements: Type size no less than 1/16" unless smaller size established by regulation [21 CFR 740.2]. Letter Height: The lower case letter "o" or equivalent when upper and lower case letters are used [21 CFR 701.13(h)].
21 CFR 701.2(a) (b), 701.3(b), 701.11(c), 701.13(i), 740.2(b) Sec. 4 of the FP&L Act [21 U.S.C. 14554] requires that a consumer commodity bear a statement of identity. Regulations [21 CFR 701.11] published by the FDA require that the identity statement appear on the PDP. The identity of the commodity may be expressed in terms of the common or usual name of the cosmetic, a descriptive name, or when the nature of the cosmetic is obvious, a fanciful name. It may also be expressed in form of an illustration. The identity statement must be in bold type and in a size reasonably related to the most prominent printed matter which is usually the name of the cosmetic. It must be in lines generally parallel to the base on which the product rests when displayed at retail.
Identity Labeling
Common or usual name Descriptive name Fanciful name Illustration Prominence Placement
21 CFR 701.11 The name and business address appearing on the label may be those of the manufacturer, packer or distributor. If the name and address is not that of the manufacturer, the name must be preceded by phrases such as "Manufactured for ...", "Distributed by ...", or other appropriate wording. The name of the firm must be the corporate name, and the address may be that of the principal place of business. Stating also the name of a corporation's particular division is optional. The business address must include the street address, name of the city and state, and the ZIP code. The street address may be omitted if the firm is listed in a current city or telephone directory. The Tariff Act of 1930 requires that imported products state on the label the English Name of the country of origin.
6 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
the panel of a display card to which the container is affixed. Prominence: The declaration must be a distinct item, separated from other printed matter by a space equal to at least the height of the lettering used in the declaration and twice the width of the letter "N". Conspicuousness: The print must be easily legible bold face type in distinct contract to background and other matter on the package. The letter height must be at least that of the lower case letter "o", and the aspect ratio of height to width must not exceed 3:1. The type size, as determined by the area of the PDP must be at least 1/16 in. if PDP area < 5 sq. in., 1/8 in. if PDP area > 5 to < 25 sq. In., 3/16 in. if PDP area > 25 to < 100 sq. in., and 1/4 in. if PDP area > 100 sq. in.
Quantity of Contents
Location on Package On PDP On information panel
Prominence Placement Spacing Conspicuousness Contract Letter height Aspect ration Type size
Cosmetics in packages containing less than 1/4 av. oz. or 1/8 fl. oz. are exempt from the net quantity of contents declaration if affixed to a properly labeled display card or sold at retail in a properly labeled outer container [21 CFR 1.24]. When a cosmetic is required to bear net quantity of contents declarations on the inner and outer container, the declaration on the outer container must appear on the PDP; on the inner container, it may appear on an information panel other than the panel bearing the name of the product, i.e., the front panel.
7 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
thereof. Fluid measures exceeding one pint, but being less than one gallon, must be expressed in terms of the total number of fluid ounces followed, in parenthesis, by the number of quarts, pints and ounces or by the fractions of the quart or pint. Examples: Net Wt. 24 oz. (1 lb. 8 oz.) Net Wt. 24 oz. (1 - 1/2 lb.) Net Wt. 24 oz. (1.5 lb.) 56 fl. oz. (1 qt. 1 pt. 8 fl. oz.) 56 fl. oz. (1 qt. 1-1/2 pt.) 56 fl. oz. (1 qt. 1.5 pt.) 56 fl. oz. (1-3/4 qt.) Declaration of fractions: Fractions may be expressed in terms of common fractions ranging from 1/2 to 1/32 or as decimal fractions of no more than two significant numbers.
Quantity of Contents
Accuracy
701.13 (g) and (s)
Declaration of Fractions
701.13 (d)
Examples"Net Wt. 6 Oz." or "6 oz. Net Wt." of Net Quantity Statements
"Net Contents 6 fl. Oz." or "Net 6 Fl. Oz." or "6 Fl. Oz." "Net Wt. 1/4 Oz." or "Net Wt. 0.25 Oz." "Net 1/8 Fl. Oz." or "0.12 FL. Oz." "Net Wt. 24 Oz. (1-1/2 Lbet" or "Net Wt. 24 Oz. (1.5 Lb.) "Net 56 Fl. Oz. (1 Qt. 1 Pt. 8 Fl. Oz.)" or "... (1 Qt. 1-1/2 Pt.)" or "... (1 Qt. 1.5 Pt.)"
Economy Size: Representations of this type are permitted if the firm offers at least one other packaged size of the same brand, only one is labeled "economy size," and the unit price of the package so labeled is substantially (at least 5%) reduced compared to that of the other package. Giant Pint, Full Quart: Supplemental statements describing the net quantity of contents are permitted on panels other than the PDP. However, these statements must not be deceptive or exaggerate the amount present in the package. Six Applications: Declarations by numerical count or linear or area measure may be augmented by statements of weight or size of individual units or total weight or measure to give accurate information. These are not regarded as separate statements and must appear on the PDP. Cosmetic Kit: If a package contains the integral components making up a kit and delivers the components in the manner of an application as, for example, a home permanent wave kit, the net contents declaration may be stated in terms of the number of applications as per given instructions [21 CFR 701.13 (g) (2)].
8 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
Regulations require that "[the label of a cosmetic product shall bear a warning statement whenever necessary or appropriate to prevent a health hazard that may be associated with the product" [21 CFR 740(1)]. A cosmetic not bearing a necessary warning statement may be considered misbranded under sec. 602(a) of the FD&C Act because it fails to reveal a fact "material ... with respect to consequences which may result from the use of the article" [sec 201(n), FD&C Act]. Prominence: A warning statement must appear on the label prominently and conspicuously as compared to other words, statements or designs so that it is likely to be read by ordinary consumers at the time of purchase and use. Conspicuousness: The lettering must be in bold type on contrasting background and may in no case be less than 1/16 inch in height.
21 CFR 740 (1) and (2) A cosmetic is considered misbranded if its safety has not adequately been substantiated, and it does not bear the following conspicuous statement on the PDP: Warning - The safety of this product has not been determined. The safety of a cosmetic may be considered adequately substantiated if experts qualified by scientific training and experience can reasonably conclude from the available toxicological and other test data, chemical composition, and other pertinent information that the product is not injurious to consumers under conditions of customary use and reasonably foreseeable conditions of misuse. The safety of a cosmetic can adequately be substantiated by: a. Reliance on available toxicological test data on its ingredients and on similar products, and b. Performance of additional toxicological and other testing appropriate in the light of the existing data. Even if the safety of each ingredient has been substantiated, there usually still is at least some toxicological testing needed with the formulated product to assure adequate safety substantiation.
Warning--Avoid spraying in eyes. Contents under pressure. Do not puncture or incinerate. Do not store at temperature above 120F. Keep out of reach of children.
21 CFR 740.11 (a) If the propellant of a cosmetic packaged in a self-pressurized container consists in whole or in part of a halocarbon or hydrocarbon, the label must bear a second warning as stated below. This second warning is not required for the following products: 1.Aerosol foam or cream products containing less than 10% propellant. 2.Products which do not expel the propellant at the time of use. Examples: products with built-in piston barrier or propellant bag. 3.Metered spray products of less than 2 oz. net contents. 4.Aerosol products of less than 1/2 oz. net contents.
Cosmetic Aerosols
9 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
Warning--Use only as directed. Intentional misues by deliberately concentrating and inhaling the contents can be harmful or fatal.
21 CFR 740.11 (b) A feminine deodorant spray which, for the purpose of this regulation, is defined as "any spray deodorant product whose labeling represents or suggests that the product is for use in the female genital area or for use all over the body" must bear the caution stated below. If the expelled product does not contain a liquefied halocarbon or hydrocarbon propellant, the sentence "Spray at least 8 inches from skin" may be omitted. The regulation further states that the use of the word "hygiene" or "hygienic" or similar words renders any such product misbranded.
Cosmetic Aerosols
Caution--For external use only. Spray at least 8 inches from skin. Do not apply to broken, irritated, or itching skin. Persistent, unusual odor or discharge may indicate conditions for which a physician should be consulted. Discontinue use immediately if rash, irritation, or discomfort develops.
21 CFR 740.12 A foaming detergent bath product--also known as bubble bath product--is, for the purpose of this regulation, defined as "any product intended to be added to a bath for the purpose of producing foam that contains a surface-active agent serving as a detergent or foaming ingredient." The caution stated below is required on the label of any foaming detergent bath product which is not clearly labeled as intended for use exclusively by adults. The following are two examples of label statements identifying a product as intended for use exclusively by adults: "Keep out of reach of children" and "For adult use only." If the bubble bath product is intended for use by children, the phrase "Keep out of reach of children" may be expanded to further read "except under adult supervision." The regulation further requires that the label "Shall bear adequate directions for safe use" of the product.
Caution--Use only as directed. Excessive use of prolonged exposure may cause irritation to skin and urinary tract. Discontinue use if rash, redness or itching occurs. Consult your physician if irritation persists. Keep out of reach of children.
21 CFR 740.17 Cosmetic ingredient labeling became an issue in the early 1970s. Guidelines for ingredient labeling were published in mid-1972. Regulations were proposed in early 1973. After publication of two final regulations, stays of final regulations, terminations of stays, and lengthy court proceedings challenging the legality of the published regulations, the requirement for cosmetic ingredient labeling became fully effective in early 1977. The regulations requiring the declaration of cosmetic ingredients were published under the authority of the FP&L Act [secs. 5(c) and 6(a); 15 U.S.C. 1454 and 1455] and FD&C Act [sec. 701(e); 21 U.S.C. 371(e)]. Since the FP&L Act applies only to consumer commodities and their packages as defined in the Act, cosmetic ingredient declarations are required only on the label of the outer container of cosmetics customarily sold at retail or used in the performance of services conducted within the households. It does not apply, for example, to products used at professional establishments or samples distributed free of charge, unless such products are customarily also sold at retail, even if they were labeled "For professional use only." The ingredients must be declared in descending order of predominance. Exceptions to this requirement are discussed later.
Declaration of ingredients except flavor, fragrance, and trade secret ingredients in descending order of predominance
21 CFR 701.3 The ingredient declaration may appear on any information panel of the package which is the outer container in form of a folding carton, box, wrapper etc. if the immediate container is so packaged, or which is the jar, bottle, box etc. if the immediate container is not packaged in an outer container. It may also appear on a tag, tape or card firmly affixed to a decorative or small size container. Prominence: The declaration must appear with prominence and conspicuousness so that it is likely to be read and understood (read with ease) by ordinary individuals under normal conditions of purchase. The letters must not be obscured by design, vignettes, background or crowding. Type Size: Not less than 1/16 inch in height. It may be not less than 1/32 inch in height if the total surface area available to bear labeling (which excludes bottom, shoulder, neck, flange, decorative or sculptured surfaces) is less than 12 square inches.
10 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
The type size consisting of upper and lower case letters is determined by the height of the lower case letter "o".
Identification of Ingredients by
The name established by the commissioner as specified in 701.30. The name adopted for the ingredient as listed in: (a) CTFA Cosmetic Ingredient Dictionary (b) United States Pharmacopeia (c) National Formulary (d) Food Chemical Codex (e) USAN and the USP Dictionary of Drug Names The name generally recognized by consumers The chemical or technical name or description
21 CFR 701.3(c) t be utilized for identification of an ingredient name. If none lists a name for an ingredient, the name generally recognized by consumers, or the chemical or technical name or description, must be used. The ingredients must be listed in descending order of predominance. However, there are a few exceptions to this requirement. 1. If the cosmetic is also a drug, section 502(c) of the FD&C Act requires that the active drug ingredient(s) be declared before declaration of the cosmetic ingredients. A declaration, thus, would read as follows: "Active Ingredient: ... (Name of drug ingredient). Other (or Cosmetic) Ingredients: ... (Names of cosmetic ingredients in descending order)." [ 701.3(d)] 2. Ingredients present at a concentration not exceeding 1% may be listed in any order after the listing of the ingredients present at more than 1% in descending order of predominance. [ 701.3(f)(2)] 3. Color additives of any concentration may be listed in any order after the listing of the ingredients which are not color additives [ 701.3(f)(3)]. 4. The name of an ingredient accepted by FDA in accordance with the procedure established in 720.8 as a trade secret need not be disclosed on the label. In lieu of declaring the name of that ingredient, the phrase "and other ingredients" may be used at the end of the ingredient declaration [ 701.3(a)].
11 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
Order of Predominance
Lipstick Incorrect Label Copy Caster Oil (58) Beeswax (6.5) Candelilla Wax (6.5) Carnauba Wax (3) Lanolin (8) Ozokerite (2) Propylene Glycol (and) BHA (And) Propyl Gallate (And) Citric Acid (13) Correct Label Copy Castor Oil Lanolin Beeswax Candelilla Wax Carnauba Wax Ozokerite Propylene Glycol BHA Propyl Gallate Citric Acid Titanium Dioxide (2) Fragrance D&C Red No. 21 (2) Titanium Dioxide D&C Red No. 6 Barium Lake (4) D&C Yellow No. 5 Aluminum Lake (5) D&C Red No. 21 D&C Red No. 6 Barium Lake Fragrance (0.5) D&C Yellow No. 5 Aluminum Lake
The hypothetical pressed powder formulation portrayed in this example illustrates the two options for the listing of ingredients. On the left side, the ingredients are listed in descending order of predominance according to 701.3(2). On the right side, the ingredients are listed according to 701.3(f)(1), (2), and (3), i.e., ingredients other than colors present at a concentration exceeding 1% in descending order or predominance, followed by ingredients other than colors present at 1% or less in any order, followed by colors present at any concentration listed in any order.
Fragrance and flavor compounds may be declared in descending order of predominance as "fragrance" and "flavor." If a fragrance compound also serves as a flavor, it must be declared as "flavor and fragrance." The components (ingredient) of a fragrance or flavor may also be declared individually by their appropriate label names. The ingredient or mixture of ingredients acting as a masking agent, i.e., covering the undesirable off-odor of a product without adding a discernable odor to it, may be declared by their individual name(s) or as "fragrance" (in lieu of a better designation). A masking agent present in a product at an insignificant level may be considered an incidental ingredient under 701.3(1)(2)(iii)
12 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
A trade secret may consist of any formula, pattern, device or compilation of information which is used in one's business and which gives one an opportunity to obtain an advantage over competitors who do not know or use it.
21 CFR 20.61 The first step in processing a request for trade secrecy, i.e., a request for exemption from label declaration, of the identity of a cosmetic ingredient is the submission to FDA of the following information: (a) A semi-quantitative cosmetic formulation statement of the product in question on forms FD-2512 and 2512a. (b) A full statement of the factual and legal grounds for the request, including all data and other information on which the petitioner relies (as well as any information known to the petitioner that is unfavorable to petitioner's position). The statement of factual grounds should include scientific or technical data, reports, tests, and other relevant information that address the factors FDA considers in determining whether the identity of an ingredient qualifies as a trade secret. (The factors FDA considers are stated elsewhere.) (c) A statement that the identity of the ingredient in question has not previously been disclosed to anyone without appropriate safeguards for secrecy as further explained in 20.81.
13 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
Submission of Information Cosmetic formulation or raw material composition statement (Form 2512 or 2513) Statement of factual and legal grounds justifying trade secrecy Statement of prior non-disclosure ( 20.81). Review of data for adequacy
21 CFR 720.8 When the submitted information is sufficient to permit a review of the merits of a request, FDA proceeds with the review. When the agency concurs with petitioner and decides that the ingredient identity is a trade secret, the request for exemption from label disclosure is granted. If FDA does not concur with petitioner, the agency tentatively denies the request. The person requesting trade secrecy is informed in writing of the agency's determination. In case of a tentative denial, FDA informs petitioner of the grounds on which it relied in making this tentative determination.
14 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
2. Does the information have value? (a) Importance to the product (b) Product profitability (c) Future market performance of product (d) Effort and financial resources invested
The factor concerning the ease or difficulty with which the identity of the ingredient in question could properly be acquired or duplicated by others may be addressed by documenting an ingredient's rare or unexpected use for the intended purpose in cosmetics of a particular product category or by demonstrating the complexity of the analytical methodology necessary to identify it.
15 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
structure of the skin, it is also a drug. The product categories "drug" and "cosmetic" are not mutually exclusive. This is recognized in sec. 509 of the FD&C Act. If a cosmetic is also a drug, the label must list first the established name of the drug ingredient(s) and the quantity, kind and proportion of any alcohol, in compliance with sec. 502(e) of the FD&C Act, as "Active Ingredients" and then the remaining ingredients, in compliance with 701.3(a) or (f), as "Cosmetic Ingredients."
Ingredients"
The remaining ingredients, in compliance with 701.3, as "Cosmetic Ingredients"
21 CFR 701.3(d) This hypothetical aerosol antiperspirant formulation illustrates on the right side the correct label declaration of the ingredients of a cosmetic which is also a drug. The active drug ingredient aluminum chlorohydrate is identified as "Active Ingredient" in accordance with sec. 502(e) of the FD&C Act. The remaining ingredients may be identified as "Cosmetic Ingredients" as shown or as "Other Ingredients."
16 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
not significantly increase the concentration of the declared ingredient. Example: Sodium hydroxide added to a sodium stearate and stearic acid-containing cosmetic. 3. A substance added to a cosmetic during manufacture for its technical effect in processing but present in the finished cosmetic at an insignificant level and not having any technical or functional effect in that cosmetic. Example: Defoaming agent. 4. A substance added to a cosmetic as a component of a cosmetic ingredient and having no technical or functional effect in the finished cosmetic. Example: Preservative of a raw material added to a cosmetic as an ingredient at a concentration which reduces the preservative to a level at which it is no longer effective.
Incidental Ingredients
Definition: or Any ingredient of another ingredient or processing aid present at an insignificant level and having no technical or functional effect Need not be declared
701.3(1) The ingredients of the units of cosmetics marketed as multiunit or multicomponent packages must be declared on the label of the outside container. They must also be declared on the labels of the inside containers of the units if the inside containers are customarily separated from the outer container for individual retail sale. A MULTIUNIT package is a package which contains an assortment of similar or dissimilar products. Examples: A shade assortment of eye shadows in an eye make-up kit or a gift set consisting of a lotion, powder and toilet water in a gift box. A MULTICOMPONENT package is "a package which contains the integral components making up a complete kit, and which is designed to deliver the components in the manner of an application." See 21 CFR 701.13(g)(2). Examples: A hair coloring kit consisting of dye solution and hydrogen peroxide or a permanent wave set consisting of thioglycolate solution and sodium bromate solution.
17 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
An assortment of products of similar composition and intended for the same use in a package with a total surface area available for labeling of 12 square inches or more as, for example, two toilet waters of different fragrance or color in a gift set, may bear either: A conventional ingredient declaration in which the ingredients of each product are identified under appropriate product headings, listing either all the ingredients in descending order of predominance according to 701.3(a) or listing the ingredients according to 701.3(f), declaring first in descending order the ingredients other than colors present at concentrations exceeding 1%, followed in any order by the ingredients other than color present at concentrations of 1% or less, followed in any order by the color additives present at any concentration, or An alternate ingredient declaration, listing: 1. The ingredients other than colors common to all products in cumulative descending order of predominance according to 701.3(a), or according to 701.3(f) [permitting listing of ingredients present at 1% or less in any order], followed by 2. The ingredients other than color not common to all products, identified by the products in which they are present, followed by 3. The color additives of all products without identification of products in which they are present.
Assortments of Similar Products Intended for Same Use Available Labeling Surface Area 12 Square Inches or More
Alternate Declaration Ingredients common to all products listed in cumulative descending order of predominance (or according to paragraph (f)), and Ingredients not common to all products identified by product in which used, and Single composite list of all color additives without product identification
21 CFR 701.3 (O) (1) An assortment of products of similar composition and intended for the same use in a package with a total surface area available for labeling of less than 12 square inches as, for example, several eye shadows in a compact, may bear either: A conventional ingredient declaration in which the ingredients of each product are identified under appropriate product headings, listing either all the ingredients in descending order or according to 701.3(a) or listing the ingredients according to 701.3(f), declaring first in descending order the ingredients other than colors present at concentrations exceeding 1%, followed in any order by the ingredients other than color present at concentrations of 1% or less, followed in any order by the color additives present at any concentration, or
18 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
An alternate ingredient declaration listing the ingredients of all products in a single integrated list in cumulative descending order of predominance according to 701.3(a), or cumulatively according to 701.3(f).
Assortments of Similar Products Intended for Same Use Available Labeling Surface Area Less Than 12 Square Inches
Alternate declaration Single list of all ingredients in cumulative descending order of predominance or Single list of all ingredients according to paragraph (f)
21 CFR 701.3 (o) (2) This example of an assortment consisting of two similar hypothetical eye shadow formulations demonstrates the optional ingredient declarations for packages with a total surface area available for labeling of 12 square inches or more (center) and for packages with a total surface area available for labeling of less than 12 square inches (right side). On the left side are shown two conventional ingredient declarations, each representing one shade. In the center is shown the integrated ingredient declaration for the two shades in the package with 12 square inches or more of available labeling area. Note that the ingredients other than color not common to all products are listed after the ingredients that are common and are identified by the products in which they are used. (Bentonite in Blue Shade, Lanolin in Green Shade.) On the right side is shown the integrated ingredient declaration for the two shades in the package with less than 12 square inches of available labeling area. Note that the ingredients not common to all formulations need not be identified by the products in which they are used.
According to 701.3(g)(2) and (o)(3), a branded shade line may be defined as a line of individually packaged eye or facial make-up cosmetics or nail enamels bearing a label that is shared with other products, i.e., bearing the same product name. Example: A line of lipsticks with the same brand name. According to 701.3(g)(2) and (o)4), a branded shade line assortment may be defined as several assortments of eye or facial make-up cosmetics or nail enamels in packages bearing the same label. Example: Several compacts with the same name and label, each containing several eye shadows. According to 701.3(g)(2) and (o)(4), a branded shade line assortment may be defined as several assortments of eye or facial make-up cosmetics or nail enamels in packages bearing the same label. Example: Several compacts with the same name and label, each containing several eye shadows.
19 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
Branded Shade Lines and Branded Shade Line Assortments Alternate Declaration
Single ingredient declaration for all branded shades listing ... Ingredients common to all products, in cumulative descending order of predominance Ingredients not common, identified by product in which used Color additives common to all products, in any order Color additives not common, preceded by "May contain"
21 CFR 701.3 (g) (2) and (o) (3) (g) (2) and (o) (4) This example of a hypothetical shade of a line of lipsticks bearing the same brand name illustrates three common errors found in cosmetic ingredient declarations, namely: 1. Proprietary mixtures of ingredients identified in the ingredient dictionary by a parenthetical "(and)" are often declared on the label as shown in the dictionary section listing chemical/trade names and their respective label names. The compounds of such mixtures must be separated, the "(and)" omitted, and the components treated as individual ingredients for labeling purposes. See "Mica (and) Titanium dioxide (and) Iron oxides." 2. Many labels list all color additives of a shade line after the phrase "May contain." The color additives common to all shades must be listed before "May contain", and only those not found in all shade formulations may be listed after "May contain." 3. The ingredients other than colors which are not included in all shade formulations must be identified as to the shades in which they are present.
Lipstick - Cherry Red Incorrect Label Copy Correct Label Copy Castor Oil Castor Oil Isopropyl Myristate Isopropyl Myristate Beeswax Beeswax Candelilla Wax Candelilla Wax Oleyl Alcohol Oleyl Alcohol Ozokerite Ozokerite Sorbitan Trioleate Sorbitan Trioleate in Pearl Peach and Pearl Cherry May contain: Shades Mica (and) Titanium Dioxide (and) Iron Titanium Dioxide Oxides D&C Red No. 21 D&C Red No. 21 D&C Orange No. 5 D&C Orange No. 5 May contain: D&C Red No. 6 Barium Lake Mica D&C Red No. 7 Calcium Lake Iron Oxides D&C Red No. 27 Aluminum Lake D&C Red No. 6 Barium Lake D&C Orange No. 5 Aluminum Lake D&C Red No. 7 Calcium Lake D&C Yellow No. 10 Aluminum Lake D&C Red No. 27 Aluminum Lake D&C Orange No. 5 Aluminum Lake D&C Yellow No. 10 Aluminum Lake
Direct mail cosmetics may utilize off-package ingredient labeling as an alternative to the declaration of ingredients on an information panel. For the purpose of cosmetic ingredient labeling, direct mail cosmetics are defined as cosmetics ordered by mail and delivered to consumers through the mail without the involvement of an intermediary sales agent. Cosmetics sold to consumers through "door-to-door" salespersons are not considered direct mail cosmetics even though they
20 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
21 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
21 CFR 701.3(i) Among the various conditions described in 701.3(j) and (k) that must be met if off-package ingredient labeling is utilized as an alternative to the declaration of ingredients on an information panel, the following deserve particular attention: 1. The display unit or chart must bear the statement "Federal law requires ingredient lists to be displayed here" in letters not less than 3/16 of an inch in height. This statement becomes conspicuous when the last ingredient list has been taken or may also be shown at all times adjacent to the holder of labeling bearing the ingredient declaration(s).
1. Leaflets must bear declarations of all products sold with display unit or chart. 2. Leafoets must be identical.
Additional Requirements
22 de 23
11/10/2011 03:33 PM
http://www.fda.gov/cosmetics/cosmeticlabelinglabelclaims/cosmeticlab...
21 CFR 701.3 (k) 3. The number of copies of padded sheets or leaflets provided with each shipment of a cosmetic must be sufficient so that each purchaser may obtain a copy of an ingredient declaration. Further, the display units and replacement labeling must be accompanied by appropriate instructions to the retailer to assure that retailers display the padded sheets or leaflets. 4. Shipments of refill items also must be accompanied by sufficient copies of ingredient declarations, and the container holding the refill items and the respective copies of ingredient declarations must not contain other cosmetic products.
3. Leaflets and displays must be shipped together. 4. Leaflets must be sufficient in number and replaced with refills with replacement instructions to retailer.
21 CFR 701.3 (k) 5. The firm engaged in off-package cosmetic ingredient labeling must promptly mail a copy of the ingredient declaration to any person requesting it. 6. In case of a formulation change, the new padded sheet or leaflet must be dated if not shipped together with the display unit or chart. If a padded sheet or leaflet is to be used in conjunction with the old and the new formulations, it must bear both ingredient declarations, and the declarations must be identified in a way that the purchaser can determine which declaration pertains to which product. As an alternative, the padded sheet or leaflet bearing the two ingredient declarations may advise the purchaser that the formulation has been changed and that either declaration may be applicable.
Additional Requirements
5. Label firm must send copy of ingredient declaration to requesting person. 6. In case of formulation change, leaflet must declare both formulations.
21 CFR 701.3 (k)
Additional Requirements
23 de 23
11/10/2011 03:33 PM